Just diagnosed with Neuroleptic malignant syndrome?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Neuroleptic malignant syndrome, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Neuroleptic malignant syndrome hub →Overview
Neuroleptic malignant syndrome is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Neuroleptic malignant syndrome so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:94093 · ICD-10 G21.0 · GARD 0007195
Find care for Neuroleptic malignant syndrome
Authoritative references for Neuroleptic malignant syndrome
Research & market landscape for Neuroleptic malignant syndrome
Following Neuroleptic malignant syndrome for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Neuroleptic malignant syndrome — the real-world landscape behind the condition, in one place.
- Latest Neuroleptic malignant syndrome research on PubMed ↗
- Recruiting Neuroleptic malignant syndrome trials on ClinicalTrials.gov ↗
- Explore the Neuroleptic malignant syndrome research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Neuroleptic malignant syndrome and every rare condition. See how Tomeko works with industry →
Common questions
What is Neuroleptic malignant syndrome?
Neuroleptic malignant syndrome is a rare condition. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Neuroleptic malignant syndrome together in one place.
What are the symptoms of Neuroleptic malignant syndrome?
Symptoms of Neuroleptic malignant syndrome vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Neuroleptic malignant syndrome.
How is Neuroleptic malignant syndrome treated?
Treatment for Neuroleptic malignant syndrome depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Neuroleptic malignant syndrome, and review current options with them.
What causes Neuroleptic malignant syndrome — is it genetic?
The cause and inheritance of Neuroleptic malignant syndrome are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Neuroleptic malignant syndrome can explain what it means for you and your family.
I was just diagnosed with Neuroleptic malignant syndrome — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Neuroleptic malignant syndrome, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Neuroleptic malignant syndrome?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Neuroleptic malignant syndrome, filtered to your area.
Are there clinical trials for Neuroleptic malignant syndrome?
Tomeko shows live, recruiting studies for Neuroleptic malignant syndrome from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion
